维普期刊资源整合服务平台（V6.5）

76篇 您的检索式：作者名="Labinaz"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Robust viability of hybrid systems 显示文摘	Labinaz G Guay M	2008	Nonlinear Analysis : Hybrid Systems2008，，2：	1
2	Usefulness of mean platelet volume as a biomarker for long-term outcomes after percutaneous coronary intervention显示文摘	Goncalves SC Labinaz M Le May M	2011	Am J Cardiol2011，107，：	1
3	Meta-analysis of clinical efficacy and bleeding risk with intravenous GP IIb/IIIa antagonists for percutaneous coronary intervention显示文摘	Labinaz M Ho C Banerjee S	2007	Can J Cardiol2007，23，12：	1
4	A survey of modeling and control of hybrid systems显示文摘	Labinaz G Bayoumi M M Rudie K	1997	Annual Reviews in Control1997，21，：	1
5	2-Year Follow-Up of Patients Undergoing Transcatheter Aortic Valve Implantation Using a Self-Expanding Valve Prosthesis显示文摘	Lutz Buellesfeld Ulrich Gerckens Gerhard Schuler Raoul Bonan Jan Kovac Patrick W. Serruys Marino Labinaz Peter den Heijer Michael Mullen Wayne Tymchak Stephan Windecker Ralf Mueller Eberhard Grube	2011	Journal of the American College of Cardiology2011，，16：	1
6	Time course and importance of neoadventitial formation in arterial remodeling following balloon angioplasty of porcine coronary arteries显示文摘	Labinaz M Pels K Hoffert C	1999	Cardiaovasc Res1999，41，：	1
7	Meta-analysis of clinical efficacy and bleeding risk with intravenous glycoprotein Ⅱb/Ⅲa an tagonists for percutaneous coronary intervention显示文摘	Labinaz M Ho C Banerjee S	2007	Can J Cardiol2007，23，12：	1
8	Usefulness of mean platelet volume as a biomarker for long-term outcomes after percuta- neous coronary intervention显示文摘	Goncalves SC Labinaz M Le May M	2011	Am J Cardiol2011，107，2：	1
9	Usefulness of mean platelet volume as a biomarker for long-term outcomes after percutaneous coronary intervention 显示文摘	Goncalves SC Labinaz M Le May M	2011	AM J Cardiol2011，107，：	1
10	Usefulness of Mean Platelet Volume as a Biomarker for Long-Term Outcomes After Percutaneous Coronary Intervention显示文摘	Sandro Cadaval Goncalves Marino Labinaz Michel Le May Chris Glover Michael Froeschl Jean-Francois Marquis Edward O’Brien Dino Shukla Peter Ruchin Dharmendra Sookur Andrew Ha Derek So	2011	The American Journal of Cardiology2011，，2：	1
11	Usefulness of mean platelet volume as a biomarker for long-term outcomes after percutaneous coronary intervention显示文摘	Goncalves SC Labinaz M Le May M	2011	Am J Cardiol2011，107，2：	1
12	Meta-analysis of clinical efficacy and bleeding risk with intravenous glyco-protein Ⅱ b/Ⅲ a antagonists for percutaneous coronary in-tervention显示文摘	Ho C Banerjee S	2007	Can J Cardiol2007，23，12：	1
13	Tune course and importance of neoadventitial formation in arterial mnodeling following balloon angioplasty of porcine coronary arteries显示文摘	Labinaz M Pels K Hoffert C	1999	Cardiovasc Res1999，41，1：	1
14	Delivery of primary percutaneouscoronary intervention for the management of acute ST segment elevationmyocardial infarction : summary of the Cardiac CareNetwork of OntarioConsensus Report显示文摘	Labinaz M Swabey T Watson R	2006	Can J Cardilo Vol2006，22，3：	1
15	Association between completeness of pereutaneous coronary revaseularization and postprocedure outcomes显示文摘	MeLellan CS Ghali WA Labinaz M	2005	Am Heart J2005，150，4：	1
16	Endoglin is overexpressed after arterial injury and is required for transforming growth factor-beta-induced inhibition of smooth muscle cell migration显示文摘	Ma X Labinaz M Goldstein J	2000	Arterioscler Thromb Vasc Biol2000，20，12：	1
17	Hospitalization costs of primary stenting versus thrombolysis in acute myocardial infarction: cost analysis of the Canadian STAT Study 显示文摘	Le May MR Davies RF Labinaz M	2003	Circulation2003，108，21：	1
18	Usefulness of meanplatelet volume as a biomarker for long-term outcomes afterpercutaneous coronary intervention显示文摘	Goncalves Sandro Codaval Labinaz	2011	The American journal ofcardiology2011，107，2：	1
19	Usefulness of mean platelet volume as a biomarker for long-term outcomes after per- cutaneous coronary intervention 显示文摘	Goncalves SC Labinaz M Le MM	2011	Am J Cardiol2011，107，2：	1
20	Meta-analysis of clinical efficacy and bleeding risk with intravenous glycoprotein IIb/IIIa antagonists for percutaneous coronary intervention显示文摘	Labinaz M Ho C Banerjee S	2007	Can J Cardiol2007，23，12：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示